DISHMAN CARBOGEN AMCIS
Back to Income Statement
|
DISHMAN CARBOGEN AMCIS Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹2,413 Cr | ₹2,141 Cr | ₹1,912 Cr | ₹2,044 Cr | ₹2,059 Cr |
What is the latest Revenue of DISHMAN CARBOGEN AMCIS ?
Year | Revenue |
---|---|
Mar2024 | ₹2,413 Cr |
Mar2023 | ₹2,141 Cr |
Mar2022 | ₹1,912 Cr |
Mar2021 | ₹2,044 Cr |
Mar2020 | ₹2,059 Cr |
How is Revenue of DISHMAN CARBOGEN AMCIS Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹2,413 Cr | 12.72 | |
Mar2023 | ₹2,141 Cr | 11.96 | |
Mar2022 | ₹1,912 Cr | -6.44 | |
Mar2021 | ₹2,044 Cr | -0.73 | |
Mar2020 | ₹2,059 Cr | - |
Compare Revenue of peers of DISHMAN CARBOGEN AMCIS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DISHMAN CARBOGEN AMCIS | ₹3,984.3 Cr | -4.4% | -9.6% | 52.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹401,289.0 Cr | -0.4% | -0.9% | 4.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹181,397.0 Cr | -0.7% | 1.6% | 50.2% | Stock Analytics | |
CIPLA | ₹119,955.0 Cr | -1.7% | -1.1% | -2.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹112,132.0 Cr | -1.1% | 1.6% | 13.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,657.0 Cr | -4.3% | -8% | -4.4% | Stock Analytics |
DISHMAN CARBOGEN AMCIS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DISHMAN CARBOGEN AMCIS | -4.4% |
-9.6% |
52.6% |
SENSEX | -1.1% |
-0% |
3.2% |
You may also like the below Video Courses